Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth ▴	Diluted EPS
ALLO	Allogene Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$190.89M	n/a	-65.3%	-100.0%	-$0.87
ARTV	Artiva Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$83.86M	n/a	-76.3%	-100.0%	-$3.43
BCDA	BioCardia, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$8.23M	n/a	-919.3%	-100.0%	n/a
CMPX	Compass Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$66.49M	n/a	-33.8%	-100.0%	n/a
ELOX	Eloxx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$6.00M	n/a	n/a	-100.0%	-$0.49
CRSP	CRISPR Therapeutics AG Manufacturing · Year ended 2025-12-31 · USD	$3.51M	-$581.60M	n/m	-30.3%	-90.6%	-$6.47
ALEC	Alector, Inc. Manufacturing · Year ended 2025-12-31 · USD	$21.05M	-$142.93M	-679.2%	-466.3%	-79.1%	-$1.39
IMA	ImageneBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$800.0K	-$45.35M	n/m	-34.1%	-77.1%	-$9.64
ENTX	Entera Bio Ltd. Manufacturing · Year ended 2025-12-31 · USD	$42.0K	-$11.44M	n/m	-87.3%	-76.8%	$0.25
SRZN	Surrozen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.48M	-$242.03M	n/m	n/a	-67.4%	-$32.37
MGX	Metagenomi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.21M	-$87.87M	-348.5%	-55.4%	-51.8%	-$2.36
FATE	Fate Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$6.65M	-$136.31M	n/m	-65.8%	-51.2%	-$1.15
DTIL	Precision Biosciences Inc Manufacturing · Year ended 2025-12-31 · USD	$34.26M	-$45.72M	-133.4%	-49.6%	-50.1%	-$3.56
VYGR	Voyager Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.37M	-$119.72M	-296.5%	-61.1%	-49.5%	-$2.04
AIM	AIM ImmunoTech Inc. Manufacturing · Year ended 2025-12-31 · USD	$88.0K	-$13.96M	n/m	n/a	-48.2%	-$8.62
SCLX	Scilex Holding Co Manufacturing · Year ended 2025-12-31 · USD	$30.25M	-$374.05M	n/m	n/a	-46.5%	-$36.48
CELZ	Creative Medical Technology Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.0K	-$6.00M	n/m	-79.8%	-45.5%	-$2.52
MRNA	Moderna, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.94B	-$2.82B	-145.2%	-32.6%	-39.9%	-$7.26
ALGS	Aligos Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.19M	-$24.19M	n/m	-45.2%	-39.5%	-$2.45
SGMOQ	Sangamo Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$39.55M	-$122.93M	-310.8%	n/a	-31.6%	-$0.44
DNA	Ginkgo Bioworks Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$170.16M	-$312.76M	-183.8%	-61.5%	-25.1%	-$5.64
PLUR	Pluri Inc. Manufacturing · Year ended 2026-06-30 · USD	$1.02M	-$23.82M	n/m	n/a	-24.0%	-$2.44
ATYR	aTYR PHARMA INC Manufacturing · Year ended 2025-12-31 · USD	$190.0K	-$74.12M	n/m	-109.8%	-19.1%	-$0.80
KYMR	Kymera Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$39.21M	-$311.35M	-794.0%	-19.7%	-16.7%	-$3.69
CRIS	Curis Inc Manufacturing · Year ended 2025-12-31 · USD	$9.44M	-$7.58M	-80.3%	-138.8%	-13.4%	-$0.58

Rows per page: 2550 100